IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q3 FY21 results · Oct–Dec 2020
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹513.01 crore (up 0.3% from Q3 FY20) and net profit of ₹114.81 crore (up 17.1% from Q3 FY20) for Q3 FY21 (Oct–Dec 2020), on a standalone basis.
| Item | Q3 FY21 | Q3 FY20 | YoY | Q2 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 513.01 | 511.25 | +0.3% | 533.48 | −3.8% |
| Other income | 7.81 | 3.96 | +97.2% | 4.48 | +74.3% |
| Total income | 520.82 | 515.21 | +1.1% | 537.96 | −3.2% |
| Profit before tax | 153.63 | 150.76 | +1.9% | 165.05 | −6.9% |
| Net profit for the period | 114.81 | 98.01 | +17.1% | 126.96 | −9.6% |
| EPS, basic (₹) | 19.54 | 17.22 | +13.5% | 21.61 | −9.6% |
| Net margin (%) | 22.4 | 19.2 | 23.8 |
Standalone
- Filed with BSE
- 11 Feb 2021, 12:28 IST
- Board meeting
- 10 Feb 2021
- Period
- 01 Oct 2020 to 31 Dec 2020
- Review status
- Audited
- Source
- XBRL filing on BSE